HKSE:02566 (China)
Â
Ordinary Shares - Class H
HK$
5.41
+0.16 (+3.05%)
Aug 14
Business Description
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd
ISIN : CNE100006KF0
Share Class Description:
HKSE:02566: Ordinary Shares - Class HTotal Employee Number:
1,794Compare
Compare
Traded in other countries / regions
02566.Hong Kong IPO Date
2024-11-28Description
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd is a biopharmaceutical company in China. It is engaged in the research & development, manufacturing, and commercialization of biopharmaceutical products and medical devices. The company focuses on four large and fast-growing therapeutic areas: orthopedics, metabolic diseases, oncology, and hematology. Centered around these therapeutic areas, it has built a diversified product portfolio comprising several marketed products, such as Jilifen, Jijufen, Jiouting, Yinuojia, Guyoudao, etc., and has several product candidates under development, such as JY54, JY23, JY47, JY56, JY29-2, etc., targeting various indications. Geographically, the company generates maximum revenue from the Chinese Mainland, and the rest from other countries.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.42 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | 0.77 | |||||
Interest Coverage | 28.14 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.2 | |||||
Beneish M-Score | -2.7 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.7 | |||||
3-Year EBITDA Growth Rate | 29.6 | |||||
3-Year EPS without NRI Growth Rate | 31.2 | |||||
3-Year Book Growth Rate | 28.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 61.38 | |||||
9-Day RSI | 49.22 | |||||
14-Day RSI | 45.94 | |||||
3-1 Month Momentum % | -12.07 | |||||
6-1 Month Momentum % | -38.48 | |||||
12-1 Month Momentum % | -52.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.46 | |||||
Quick Ratio | 4.01 | |||||
Cash Ratio | 2.15 | |||||
Days Inventory | 210.22 | |||||
Days Sales Outstanding | 167.36 | |||||
Days Payable | 53.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.21 | |||||
Dividend Payout Ratio | 0.1 | |||||
Forward Dividend Yield % | 1.21 | |||||
5-Year Yield-on-Cost % | 1.21 | |||||
Shareholder Yield % | -0.03 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 80.68 | |||||
Operating Margin % | 12.19 | |||||
Net Margin % | 10.58 | |||||
EBITDA Margin % | 16.19 | |||||
FCF Margin % | 11.58 | |||||
OCF Margin % | 19.6 | |||||
ROE % | 8.78 | |||||
ROA % | 6.88 | |||||
ROIC % | 11.92 | |||||
3-Year ROIIC % | 32.4 | |||||
ROC (Joel Greenblatt) % | 18.77 | |||||
ROCE % | 9.94 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 8.81 | |||||
PE Ratio without NRI | 8.81 | |||||
Price-to-Owner-Earnings | 6.56 | |||||
PS Ratio | 0.92 | |||||
PB Ratio | 0.73 | |||||
Price-to-Tangible-Book | 0.83 | |||||
Price-to-Free-Cash-Flow | 7.98 | |||||
Price-to-Operating-Cash-Flow | 4.72 | |||||
EV-to-EBIT | 3.58 | |||||
EV-to-EBITDA | 2.83 | |||||
EV-to-Revenue | 0.46 | |||||
EV-to-FCF | 3.95 | |||||
Price-to-Graham-Number | 0.57 | |||||
| Price-to-Net-Current-Asset-Value | 1.19 | |||||
| Price-to-Net-Cash | 4.92 | |||||
Earnings Yield (Greenblatt) % | 27.93 | |||||
FCF Yield % | 12.79 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 1,435.651 | ||
| EPS (TTM) (HK$) | 0.614 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 69.75 | ||
| 14-Day RSI | 45.94 | ||
| 14-Day ATR (HK$) | 0.334491 | ||
| 20-Day SMA (HK$) | 5.432 | ||
| 12-1 Month Momentum % | -52.23 | ||
| 52-Week Range (HK$) | 4.6 - 16.29 | ||
| Shares Outstanding (Mil) | 240.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| HKD 0.065540 Cash Dividend | 2026-06-17 | 5.84 (-2.67%) | ||
| HKD 0.061000 Cash Dividend | 2025-06-13 | 10.78 (+43.73%) |
Show
Entries
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd Frequently Asked Questions
What is Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd(HKSE:02566)'s stock price today?
The current price of HKSE:02566 is HK$5.41. The 52 week high of HKSE:02566 is HK$16.29 and 52 week low is HK$4.60.
When is next earnings date of Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd(HKSE:02566)?
The next earnings date of Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd(HKSE:02566) is .
Does Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd(HKSE:02566) pay dividends? If so, how much?
The Dividend Yield %  of Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd(HKSE:02566) is 1.21% (As of Today), Highest Dividend Payout Ratio of Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd(HKSE:02566) was 0.1. The lowest was 0.1. And the median was 0.1. The  Forward Dividend Yield % of Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd(HKSE:02566) is 1.21%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers